Accelerate trial timelines with centralized sample visibility.

Stop wasting R&D dollars on fragmented sample operations. See how leading biopharma teams eliminate costly errors, scale capacity without adding headcount, and bring trials to completion faster with QuartzBio’s Sample Intelligence solution.

Schedule a 15-min executive walkthrough to see the financial impact for your trials.

The hidden cost of fragmented sample data

Fragmented sample operations quietly cost biopharma teams $40K–$50K per day—delaying decisions, increasing risk, and pushing out time-to-market.

Your clinical stack is automated—except sample operations, which are still manual, fragmented and reactive.

QuartzBio’s Sample Intelligence (SI) solution closes this gap—bringing the same level of automation, visibility, and control to your sample workflows across vendors, labs, and studies—so timelines hold and data can be trusted.

What clinical and R&D leaders gain with Sample Intelligence:

  • Centralized visibility across all studies, vendors, and systems
  • Measurable impact, saving >$10M per trial by eliminating operational drag
  • Proactive detection of data integrity issues before they impact timelines
  • Faster decisions with fewer data errors and delayed milestones, and teams focused on execution, not spreadsheets

If you’re ready to quit repetitive cross-system checks, catch issues sooner, and act faster, explore Sample Intelligence.

QuartzBio Sample Intelligence - Automated Unification of Sample Ecosystem
Info Sheet: The True Costs of Sample (Mis)Management vs The QuartzBio Difference

Case Study: How a Top 5 Pharma Doubled Clinical Trial Capacity of Existing Teams

“With QuartzBio, we spend 85% less time on sample-related tasks.”
–Top Biopharma

Learn how a biomarker operations team at a top biopharma used the Sample Intelligence Solution to address fragmented systems, manual workflows, and lack of visibility across the sample lifecycle, achieving:

  • Doubled clinical trial capacity without increasing headcount
  • 98% reduction in manual reconciliation ​
  • 100% detection of missing samples—zero silent losses
  • $150k-$400k saved per study by avoiding unusable patient data

Stop letting sample operations drain time, budget, and capacity.

Leading biopharma teams are centralizing sample visibility to accelerate timelines, reduce operational waste, and scale without added headcount.

See where your trials are leaking time and cost with a 15-minute executive walkthrough.

Identify your biggest opportunities to speed time-to-revenue: